JP2023521255A - 携帯型監視デバイスからの監視を用いたユーザの健康状況の予測 - Google Patents
携帯型監視デバイスからの監視を用いたユーザの健康状況の予測 Download PDFInfo
- Publication number
- JP2023521255A JP2023521255A JP2023502877A JP2023502877A JP2023521255A JP 2023521255 A JP2023521255 A JP 2023521255A JP 2023502877 A JP2023502877 A JP 2023502877A JP 2023502877 A JP2023502877 A JP 2023502877A JP 2023521255 A JP2023521255 A JP 2023521255A
- Authority
- JP
- Japan
- Prior art keywords
- user
- value
- health status
- assessment data
- predictive model
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 19
- 238000012806 monitoring device Methods 0.000 title description 13
- 230000036541 health Effects 0.000 title description 11
- 230000003862 health status Effects 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 61
- 230000001149 cognitive effect Effects 0.000 claims abstract description 49
- 238000011156 evaluation Methods 0.000 claims abstract description 5
- 208000015181 infectious disease Diseases 0.000 claims description 58
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 15
- 208000035473 Communicable disease Diseases 0.000 claims description 12
- 238000013528 artificial neural network Methods 0.000 claims description 9
- 230000000306 recurrent effect Effects 0.000 claims description 8
- 230000002787 reinforcement Effects 0.000 claims description 7
- 238000000354 decomposition reaction Methods 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 3
- 210000001989 nasopharynx Anatomy 0.000 claims description 3
- 244000052769 pathogen Species 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 210000001331 nose Anatomy 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000002255 vaccination Methods 0.000 claims 1
- 230000015654 memory Effects 0.000 description 21
- 230000006870 function Effects 0.000 description 19
- 208000024891 symptom Diseases 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 11
- 238000012549 training Methods 0.000 description 11
- 206010016256 fatigue Diseases 0.000 description 10
- 230000002458 infectious effect Effects 0.000 description 10
- 208000025721 COVID-19 Diseases 0.000 description 8
- 208000002474 Tinea Diseases 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 230000003542 behavioural effect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000026278 immune system disease Diseases 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 241000893966 Trichophyton verrucosum Species 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 238000013527 convolutional neural network Methods 0.000 description 5
- 238000013480 data collection Methods 0.000 description 5
- 238000003066 decision tree Methods 0.000 description 5
- 230000036651 mood Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000003936 working memory Effects 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- 206010010099 Combined immunodeficiency Diseases 0.000 description 3
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 3
- 208000007514 Herpes zoster Diseases 0.000 description 3
- 102000029797 Prion Human genes 0.000 description 3
- 108091000054 Prion Proteins 0.000 description 3
- 206010061372 Streptococcal infection Diseases 0.000 description 3
- 208000007712 Tinea Versicolor Diseases 0.000 description 3
- 206010056131 Tinea versicolour Diseases 0.000 description 3
- 206010054000 Type II hypersensitivity Diseases 0.000 description 3
- 206010047115 Vasculitis Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 208000006730 anaplasmosis Diseases 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001418 larval effect Effects 0.000 description 3
- 238000010801 machine learning Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000001617 migratory effect Effects 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000008026 type II hypersensitivity Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 208000026872 Addison Disease Diseases 0.000 description 2
- 208000000230 African Trypanosomiasis Diseases 0.000 description 2
- 206010001935 American trypanosomiasis Diseases 0.000 description 2
- 206010003267 Arthritis reactive Diseases 0.000 description 2
- 206010060976 Bacillus infection Diseases 0.000 description 2
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 2
- 206010044583 Bartonella Infections Diseases 0.000 description 2
- 206010005098 Blastomycosis Diseases 0.000 description 2
- 206010005913 Body tinea Diseases 0.000 description 2
- 208000003508 Botulism Diseases 0.000 description 2
- 208000009802 Colorado tick fever Diseases 0.000 description 2
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 208000000307 Crimean Hemorrhagic Fever Diseases 0.000 description 2
- 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010073508 Drug reaction with eosinophilia and systemic symptoms Diseases 0.000 description 2
- 201000006353 Filariasis Diseases 0.000 description 2
- 201000000628 Gas Gangrene Diseases 0.000 description 2
- 208000015023 Graves' disease Diseases 0.000 description 2
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 2
- 208000000464 Henipavirus Infections Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241000701806 Human papillomavirus Species 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 208000004023 Legionellosis Diseases 0.000 description 2
- 208000016604 Lyme disease Diseases 0.000 description 2
- 208000000932 Marburg Virus Disease Diseases 0.000 description 2
- 201000011013 Marburg hemorrhagic fever Diseases 0.000 description 2
- 206010027202 Meningitis bacterial Diseases 0.000 description 2
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241001263478 Norovirus Species 0.000 description 2
- 241000243985 Onchocerca volvulus Species 0.000 description 2
- 208000010195 Onychomycosis Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 208000005384 Pneumocystis Pneumonia Diseases 0.000 description 2
- 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 description 2
- 208000000705 Rift Valley Fever Diseases 0.000 description 2
- 206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 2
- 206010054979 Secondary immunodeficiency Diseases 0.000 description 2
- 201000010618 Tinea cruris Diseases 0.000 description 2
- 206010044269 Toxocariasis Diseases 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 230000036626 alertness Effects 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 201000008680 babesiosis Diseases 0.000 description 2
- 201000009904 bacterial meningitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 201000003486 coccidioidomycosis Diseases 0.000 description 2
- 230000019771 cognition Effects 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000000292 ehrlichiosis Diseases 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 2
- 230000008921 facial expression Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 208000029080 human African trypanosomiasis Diseases 0.000 description 2
- 201000009163 human granulocytic anaplasmosis Diseases 0.000 description 2
- 208000022340 human granulocytic ehrlichiosis Diseases 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000028454 lice infestation Diseases 0.000 description 2
- 208000008588 molluscum contagiosum Diseases 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 206010028417 myasthenia gravis Diseases 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 208000005814 piedra Diseases 0.000 description 2
- 201000000317 pneumocystosis Diseases 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 208000002574 reactive arthritis Diseases 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000006403 short-term memory Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 201000002612 sleeping sickness Diseases 0.000 description 2
- 201000003875 tinea corporis Diseases 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 201000005882 tinea unguium Diseases 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 206010061393 typhus Diseases 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000010543 22q11.2 deletion syndrome Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000034950 Acinetobacter Infections Diseases 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000244023 Anisakis Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000009695 Argentine hemorrhagic fever Diseases 0.000 description 1
- 208000000104 Arthus reaction Diseases 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 208000034974 Bacteroides Infections Diseases 0.000 description 1
- 208000023328 Basedow disease Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- 241000726108 Blastocystis Species 0.000 description 1
- 241000335423 Blastomyces Species 0.000 description 1
- 201000010424 Brazilian hemorrhagic fever Diseases 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 206010069747 Burkholderia mallei infection Diseases 0.000 description 1
- 208000006448 Buruli Ulcer Diseases 0.000 description 1
- 208000023081 Buruli ulcer disease Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010051226 Campylobacter infection Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010007187 Capillariasis Diseases 0.000 description 1
- 208000028737 Carrion disease Diseases 0.000 description 1
- 208000003732 Cat-scratch disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 201000009182 Chikungunya Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 208000000362 Chlamydial Pneumonia Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 201000003874 Common Variable Immunodeficiency Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 208000008953 Cryptosporidiosis Diseases 0.000 description 1
- 206010011502 Cryptosporidiosis infection Diseases 0.000 description 1
- 206010061802 Cyclosporidium infection Diseases 0.000 description 1
- 206010050685 Cytokine storm Diseases 0.000 description 1
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000305506 Desmodesmus Species 0.000 description 1
- 208000000398 DiGeorge Syndrome Diseases 0.000 description 1
- 241000571940 Dracula Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 208000030820 Ebola disease Diseases 0.000 description 1
- 206010014096 Echinococciasis Diseases 0.000 description 1
- 208000009366 Echinococcosis Diseases 0.000 description 1
- 206010014611 Encephalitis venezuelan equine Diseases 0.000 description 1
- 208000000966 Enoplida Infections Diseases 0.000 description 1
- 206010014889 Enterococcal infections Diseases 0.000 description 1
- 206010014909 Enterovirus infection Diseases 0.000 description 1
- 206010014979 Epidemic typhus Diseases 0.000 description 1
- 206010015108 Epstein-Barr virus infection Diseases 0.000 description 1
- 208000007985 Erythema Infectiosum Diseases 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 201000005866 Exanthema Subitum Diseases 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 206010016675 Filariasis lymphatic Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010017564 Fusobacterium infections Diseases 0.000 description 1
- 206010017916 Gastroenteritis staphylococcal Diseases 0.000 description 1
- 201000003950 Geotrichosis Diseases 0.000 description 1
- 208000007465 Giant cell arteritis Diseases 0.000 description 1
- 201000003641 Glanders Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000024869 Goodpasture syndrome Diseases 0.000 description 1
- 208000003807 Graves Disease Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010061190 Haemophilus infection Diseases 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 208000021727 Hantavirus hemorrhagic fever with renal syndrome Diseases 0.000 description 1
- 206010019143 Hantavirus pulmonary infection Diseases 0.000 description 1
- 208000001204 Hashimoto Disease Diseases 0.000 description 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001335250 Heartland virus Species 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 208000032982 Hemorrhagic Fever with Renal Syndrome Diseases 0.000 description 1
- 208000025164 Hendra virus infection Diseases 0.000 description 1
- 206010062506 Heparin-induced thrombocytopenia Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000005331 Hepatitis D Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000046923 Human bocavirus Species 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 208000003352 Hyper-IgM Immunodeficiency Syndrome Diseases 0.000 description 1
- 208000007924 IgA Deficiency Diseases 0.000 description 1
- 208000001718 Immediate Hypersensitivity Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022491 Insulin resistant diabetes Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 208000011200 Kawasaki disease Diseases 0.000 description 1
- 241001454354 Kingella Species 0.000 description 1
- 206010023927 Lassa fever Diseases 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 206010024641 Listeriosis Diseases 0.000 description 1
- 208000037263 Lymphatic filariasis Diseases 0.000 description 1
- 241000712898 Machupo mammarenavirus Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010066226 Metapneumovirus infection Diseases 0.000 description 1
- 241000041810 Mycetoma Species 0.000 description 1
- 206010066289 Mycobacterium ulcerans infection Diseases 0.000 description 1
- 241000204051 Mycoplasma genitalium Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010064034 Nipah virus infection Diseases 0.000 description 1
- 206010029443 Nocardia Infections Diseases 0.000 description 1
- 206010029444 Nocardiosis Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 208000010598 Oroya fever Diseases 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 206010033767 Paracoccidioides infections Diseases 0.000 description 1
- 201000000301 Paracoccidioidomycosis Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 241000517324 Pediculidae Species 0.000 description 1
- 241000517307 Pediculus humanus Species 0.000 description 1
- 201000011152 Pemphigus Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001326499 Piedraia hortae Species 0.000 description 1
- 208000035109 Pneumococcal Infections Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 206010054161 Pontiac fever Diseases 0.000 description 1
- 206010036303 Post streptococcal glomerulonephritis Diseases 0.000 description 1
- 208000031732 Post-Lyme Disease Syndrome Diseases 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 208000031951 Primary immunodeficiency Diseases 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000287531 Psittacidae Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- 206010037688 Q fever Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010038717 Respiratory syncytial viral infections Diseases 0.000 description 1
- 208000004364 Rhinosporidiosis Diseases 0.000 description 1
- 206010061494 Rhinovirus infection Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 208000034712 Rickettsia Infections Diseases 0.000 description 1
- 206010061495 Rickettsiosis Diseases 0.000 description 1
- 206010067470 Rotavirus infection Diseases 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 241000369757 Sapovirus Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 206010039915 Selective IgA immunodeficiency Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 206010041736 Sporotrichosis Diseases 0.000 description 1
- 208000008582 Staphylococcal Food Poisoning Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 206010044608 Trichiniasis Diseases 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 208000034784 Tularaemia Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010045240 Type I hypersensitivity Diseases 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 1
- 201000009145 Venezuelan equine encephalitis Diseases 0.000 description 1
- 201000009693 Venezuelan hemorrhagic fever Diseases 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 208000006110 Wiskott-Aldrich syndrome Diseases 0.000 description 1
- 241000244005 Wuchereria bancrofti Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000035994 Yersinia pseudotuberculosis Infections Diseases 0.000 description 1
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 1
- 208000001455 Zika Virus Infection Diseases 0.000 description 1
- 201000004296 Zika fever Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000007691 actinomycosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 201000005638 acute proliferative glomerulonephritis Diseases 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000011316 allogeneic transplantation Methods 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003935 attention Effects 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 206010004145 bartonellosis Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 206010004975 black piedra Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000006824 bubonic plague Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000004927 campylobacteriosis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 201000004308 chancroid Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003280 chronobiological effect Effects 0.000 description 1
- 238000007635 classification algorithm Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 201000002641 cyclosporiasis Diseases 0.000 description 1
- 206010052015 cytokine release syndrome Diseases 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000004587 dientamoebiasis Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000006036 elephantiasis Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000005239 filarial elephantiasis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 201000006592 giardiasis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 201000005648 hantavirus pulmonary syndrome Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 201000010284 hepatitis E Diseases 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 201000009162 human monocytic ehrlichiosis Diseases 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 206010066130 hyper-IgM syndrome Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 201000007156 immunoglobulin alpha deficiency Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 201000011422 infant botulism Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000019715 inherited Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000004015 melioidosis Diseases 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 208000037941 meningococcal disease Diseases 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000005871 monkeypox Diseases 0.000 description 1
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
- 206010028320 muscle necrosis Diseases 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000003177 ocular onchocerciasis Diseases 0.000 description 1
- 208000002042 onchocerciasis Diseases 0.000 description 1
- 206010030861 ophthalmia neonatorum Diseases 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 201000005989 paraneoplastic polyneuropathy Diseases 0.000 description 1
- 208000012111 paraneoplastic syndrome Diseases 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 201000001976 pemphigus vulgaris Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 201000000508 pityriasis versicolor Diseases 0.000 description 1
- 201000006292 polyarteritis nodosa Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 238000004549 pulsed laser deposition Methods 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000007865 relapsing fever Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000029138 selective IgA deficiency disease Diseases 0.000 description 1
- 230000031893 sensory processing Effects 0.000 description 1
- 206010040400 serum sickness Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000004617 sleep duration Effects 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 201000002190 staphyloenterotoxemia Diseases 0.000 description 1
- 238000012030 stroop test Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 206010043207 temporal arteritis Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000003982 trichinellosis Diseases 0.000 description 1
- 201000007588 trichinosis Diseases 0.000 description 1
- 230000009959 type I hypersensitivity Effects 0.000 description 1
- 208000025883 type III hypersensitivity disease Diseases 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000016808 vibrio vulnificus infectious disease Diseases 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 201000000752 white piedra Diseases 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/162—Testing reaction times
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/726—Details of waveform analysis characterised by using transforms using Wavelet transforms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Neurology (AREA)
- Educational Technology (AREA)
- Social Psychology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Neurosurgery (AREA)
- Multimedia (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
本願は、2020年3月27日に提出された米国の仮出願番号63/000,607及び2020年5月29日に提出された米国の仮出願番号63/032,036のそれぞれの優先権を主張し、そのタイトルは、参照により全体がここに結合される。
2. 記憶-SAGE-自己管理の認知、陳述性記憶
3. 言語-
4. 気分と感情-CES-D、うつ病と気分のプロファイル
5. 報酬及びリスクテイク-遅延割引、報酬学習、
6. 知覚処理-視覚、聴覚、嗅覚、体性感覚/マルチモーダル
7. 疲労-精神運動覚醒タスク及びその他の注意力タスク
8. 感覚-システム、例えば嗅覚、味覚、視覚、聴覚、触覚
9. 運動
10. 神経能力
11. 社会システム
12. 社会的ネットワーク
Claims (21)
- ユーザの健康状況を監視するための方法であって、
定められた期間にわたって携帯型デバイスにおける前記ユーザを表す健康状況関連パラメータを監視して、前記健康状況関連パラメータの時系列を作成することと、
前記定められた期間内の対応する第1時間及び第2時間に、前記ユーザについて認知的評価データと心理社会的評価データのうちの一つの第1セット及び第2セットを取得することと、
前記健康状況関連パラメータの時系列、前記認知的評価データと心理社会的評価データのうちの一つの第1セット、および、前記認知的評価データと心理社会的評価データのうちの一つの第2セットに基づいて、予測モデルを介して前記ユーザに値を割り当てることと、を含む、ことを特徴とする方法。 - 前記健康状況関連パラメータの時系列に基づいて予測モデルを介して前記ユーザに値を割り当てることは、前記健康状況関連パラメータの時系列にウェーブレット分解を実行してウェーブレット係数セットを提供し、少なくとも前記ウェーブレット係数セットに基づいて前記値を割り当てることを含む、ことを特徴とする請求項1に記載の方法。
- 前記ウェーブレット係数セットの少なくとも1部の加重組合せを生成することをさらに含み、
少なくとも前記ウェーブレット係数セットに基づいて前記値を割り当てることは、少なくとも前記加重組合せに基づいて前記値を割り当てることを含む、ことを特徴とする請求項2に記載の方法。 - 前記ウェーブレット係数セットは、第1変数及び第2変数にまたがる二次元配列であり、前記方法は、前記ウェーブレット係数セットに基づいて前記二次元配列の重心を、前記第1変数の第1代表値及び前記第2変数の第2代表値として生成することをさらに含み、
ここで、少なくとも前記ウェーブレット係数セットに基づいて前記値を割り当てることは、少なくとも前記第1代表値及び第2代表値に基づいて前記値を割り当てることを含む、ことを特徴とする請求項2に記載の方法。 - 前記ユーザに関連する結果を測定することと、
測定された結果を、予測モデルを介して前記ユーザに割り当てられた前記値と比較することと、
前記測定された結果と前記予測モデルを介して前記ユーザに割り当てられた値との比較に基づいて、前記予測モデルに関連するパラメータを変更することとをさらに含む、ことを特徴とする請求項1に記載の方法。 - 前記測定された結果と前記予測モデルを介して前記ユーザに割り当てられた前記値との比較に基づいて前記予測モデルに関連するパラメータを変更することは、前記測定された結果と前記ユーザに割り当てられた前記値との類似度に基づいて、強化学習プロセスのための報酬を生成し、前記強化学習プロセスを介して前記パラメータを変更することを含む、ことを特徴とする請求項5に記載の方法。
- 前記予測モデルに関連する前記パラメータは、前記値を前記予測モデルによって提供された連続インデックスからのカテゴリ値として前記ユーザに割り当てるための決定閾値である、ことを特徴とする請求項6に記載の方法。
- 前記値は、予防接種によって前記ユーザに提供される期待免疫度である、ことを特徴とする請求項1に記載の方法。
- 前記値は、特定の病気又は病気のクラスによって前記ユーザにもたらされる予測リスクを表す、ことを特徴とする請求項1に記載の方法。
- 前記値は、前記ユーザの予測又は予報される感染性を表す、ことを特徴とする請求項9に記載の方法。
- 前記値は、前記ユーザが感染症に感染するまでの予測日数を表す、ことを特徴とする請求項10に記載の方法。
- 前記値は、前記鼻、鼻咽頭、口又は体液中のDNA、RNA又はタンパク質又は抗体測定から予測される病原体レベルを表す、ことを特徴とする請求項9に記載の方法。
- 前記予測モデルを介して前記値を前記ユーザに割り当てることは、
前記健康状況関連パラメータの時系列、前記認知的評価データと心理社会的評価データのうちの一つの第1セット、及び前記認知的評価データと心理社会的評価データのうちの一つの第2セットに基づいて、前記ユーザに前記健康状況関連パラメータの将来値を表す第1値を割り当てることと、
少なくとも前記第1値に基づいて前記値を前記ユーザに割り当てることと、を含む、ことを特徴とする請求項1に記載の方法。 - 前記健康状況関連パラメータは、心拍数変動性である、ことを特徴とする請求項1に記載の方法。
- システムであって、
定められた期間にわたってユーザを表す健康状況関連パラメータを監視して、監視されたパラメータの時系列を作成するウェアラブルデバイスと、
前記定められた期間内の対応する第1時間及び第2時間に、前記ユーザについて認知的評価データと心理社会的評価データのうちの一つの第1セット及び第2セットを受信する携帯型デバイスと、
前記健康状況関連パラメータの時系列、前記認知的評価データと心理社会的評価データのうちの一つの第1セット、及び前記認知的評価データと心理社会的評価データのうちの一つの第2セットに基づいて、前記ユーザに値を割り当てる予測モデルとを含む、ことを特徴とするシステム。 - 前記認知的評価データと心理社会的評価データのうちの一つの前記第1セット及び第2セットは、前記認知的評価データの第1セット及び第2セットであり、前記携帯型デバイスは、ユーザインターフェースを含み、前記ユーザインターフェースは、前記ユーザが前記ウェアラブルデバイスに関連するベースユニットにおける認知評価アプリケーションと対話することを可能にして、前記第1セットの認知的評価データ及び前記第2セットの認知的評価データを提供する、ことを特徴とする請求項15に記載のシステム。
- 前記予測モデルは、リカレントニューラルネットワークとして実装され、前記リカレントニューラルネットワークは、前記ユーザを表すインデックスと、強化学習モデルとを作成し、前記強化学習モデルは、前記値を前記ユーザの健康状況を表すクラスパラメータとして前記ユーザに割り当てるための決定閾値を連続的に絞り込む、ことを特徴とする請求項15に記載のシステム。
- 特徴抽出器をさらに含み、前記特徴抽出器は、前記監視されるパラメータの時系列に基づいて特徴セットを決定し、前記予測モデルは、前記特徴セット、前記認知的評価データと心理社会的評価データのうちの一つの第1セット、及び前記認知的評価データと心理社会的評価データのうちの一つの第2セットに基づいて、前記値を前記ユーザに割り当てる、ことを特徴とする請求項15に記載のシステム。
- 前記特徴抽出器は、前記健康状況関連パラメータの時系列にウェーブレット分解を実行して、ウェーブレット係数セットを提供することによって、前記特徴セットを提供する、ことを特徴とする請求項18に記載のシステム。
- 前記予測モデルは、前記健康状況関連パラメータの時系列に基づいて、前記ユーザに前記健康状況関連パラメータの将来値を表す第1値を割り当て、少なくとも前記第1値に基づいて前記ユーザに前記値を割り当てる、ことを特徴とする請求項18に記載のシステム。
- ユーザの健康状況を監視する方法であって、前記方法は、
定められた期間にわたって、ウェアラブルデバイスで前記ユーザを表す複数の健康状況関連パラメータを監視して、監視されたパラメータの対応する時系列を作成することと、
前記複数の健康状況関連パラメータの時系列から前記ユーザを表す特徴セットを抽出し、前記特徴セットは、前記複数の健康状況関連パラメータのうちの少なくとも一つの予測値を含むことと、
前記特徴セットに基づいて予測モデルを介して値を前記ユーザに割り当てることと、を含むことを特徴とする方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063000607P | 2020-03-27 | 2020-03-27 | |
US63/000,607 | 2020-03-27 | ||
US202063032036P | 2020-05-29 | 2020-05-29 | |
US63/032,036 | 2020-05-29 | ||
PCT/US2021/024617 WO2021195616A1 (en) | 2020-03-27 | 2021-03-29 | Predicting wellness of a user with monitoring from portable monitoring devices |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023521255A true JP2023521255A (ja) | 2023-05-23 |
Family
ID=77890593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023502877A Pending JP2023521255A (ja) | 2020-03-27 | 2021-03-29 | 携帯型監視デバイスからの監視を用いたユーザの健康状況の予測 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230140151A1 (ja) |
EP (1) | EP4125562A4 (ja) |
JP (1) | JP2023521255A (ja) |
KR (1) | KR20230002513A (ja) |
CN (1) | CN115443093A (ja) |
AU (1) | AU2021244627A1 (ja) |
CA (1) | CA3173456A1 (ja) |
WO (1) | WO2021195616A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023015353A1 (en) * | 2021-08-11 | 2023-02-16 | Immunosis Pty Ltd | Methods for determining secondary immunodeficiency |
WO2023096265A1 (ko) * | 2021-11-26 | 2023-06-01 | 서울대학교병원 | 생체신호를 이용한 covid-19 환자의 중증도 예측 스코어링 장치 및 그 방법 |
CN114403047B (zh) * | 2022-02-09 | 2023-01-06 | 上海依蕴宠物用品有限公司 | 一种基于图像分析技术的老龄动物健康干预方法及系统 |
US20240105335A1 (en) * | 2022-07-27 | 2024-03-28 | West Virginia University Board of Governors on behalf of West Virginia University | Analysis framework for evaluating human wellness |
WO2024181845A1 (ko) * | 2023-02-28 | 2024-09-06 | 동국대학교 산학협력단 | 가임기 여성 및 산모의 질 분비물 분석 방법 및 시스템 |
CN116671906A (zh) * | 2023-08-01 | 2023-09-01 | 亿慧云智能科技(深圳)股份有限公司 | 一种智能手表无创血糖测量方法及系统 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089187A2 (en) * | 2003-04-01 | 2004-10-21 | University Of Southern California | Caries risk test for predicting and assessing the risk of disease |
US7733224B2 (en) * | 2006-06-30 | 2010-06-08 | Bao Tran | Mesh network personal emergency response appliance |
US9526455B2 (en) * | 2011-07-05 | 2016-12-27 | Saudi Arabian Oil Company | Systems, computer medium and computer-implemented methods for monitoring and improving health and productivity of employees |
US10606353B2 (en) * | 2012-09-14 | 2020-03-31 | Interaxon Inc. | Systems and methods for collecting, analyzing, and sharing bio-signal and non-bio-signal data |
JP2016517325A (ja) * | 2013-03-15 | 2016-06-16 | サイモン、アダム、ジェイ. | 多面的生理的刺激を行うシステムおよびシグネチャ、および脳の健康評価 |
US20170308671A1 (en) * | 2016-04-20 | 2017-10-26 | Bionous, LLC | Personal health awareness system and methods |
US10463271B2 (en) * | 2016-06-07 | 2019-11-05 | NeuroSteer Ltd. | Systems and methods for analyzing brain activity and applications thereof |
US20190239791A1 (en) * | 2018-02-05 | 2019-08-08 | Panasonic Intellectual Property Management Co., Ltd. | System and method to evaluate and predict mental condition |
-
2021
- 2021-03-29 US US17/913,190 patent/US20230140151A1/en active Pending
- 2021-03-29 CA CA3173456A patent/CA3173456A1/en active Pending
- 2021-03-29 CN CN202180024902.7A patent/CN115443093A/zh active Pending
- 2021-03-29 AU AU2021244627A patent/AU2021244627A1/en active Pending
- 2021-03-29 WO PCT/US2021/024617 patent/WO2021195616A1/en unknown
- 2021-03-29 EP EP21775464.7A patent/EP4125562A4/en active Pending
- 2021-03-29 JP JP2023502877A patent/JP2023521255A/ja active Pending
- 2021-03-29 KR KR1020227037501A patent/KR20230002513A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
AU2021244627A1 (en) | 2022-11-03 |
EP4125562A1 (en) | 2023-02-08 |
CN115443093A (zh) | 2022-12-06 |
WO2021195616A1 (en) | 2021-09-30 |
EP4125562A4 (en) | 2024-04-17 |
US20230140151A1 (en) | 2023-05-04 |
KR20230002513A (ko) | 2023-01-05 |
CA3173456A1 (en) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023521255A (ja) | 携帯型監視デバイスからの監視を用いたユーザの健康状況の予測 | |
Sabry et al. | Machine learning for healthcare wearable devices: the big picture | |
Kyriakou et al. | Detecting moments of stress from measurements of wearable physiological sensors | |
US11195625B2 (en) | Method for modeling behavior and depression state | |
Shapiro et al. | Characterizing COVID-19 and influenza illnesses in the real world via person-generated health data | |
McDonald et al. | Continuous monitoring and detection of post-traumatic stress disorder (PTSD) triggers among veterans: a supervised machine learning approach | |
Fisher et al. | Unsupervised home monitoring of Parkinson's disease motor symptoms using body-worn accelerometers | |
Pateraki et al. | Biosensors and Internet of Things in smart healthcare applications: Challenges and opportunities | |
US10896756B2 (en) | Environmental sensor-based cognitive assessment | |
Vahabzadeh et al. | Digital suicide prevention: can technology become a game-changer? | |
Abdel-Basset et al. | The fusion of Internet of Intelligent Things (IoIT) in remote diagnosis of obstructive Sleep Apnea: A survey and a new model | |
US20210375485A1 (en) | Application for tracking infectious disease | |
Rizzo et al. | The brain in the wild: tracking human behavior in naturalistic settings | |
US20230187073A1 (en) | Systems and methods for predicting, detecting, and monitoring of acute illness | |
Wu et al. | A precision health service for chronic diseases: development and cohort study using wearable device, machine learning, and deep learning | |
Papakostas et al. | Distracted and drowsy driving modeling using deep physiological representations and multitask learning | |
Hunter et al. | Science fiction or clinical reality: a review of the applications of artificial intelligence along the continuum of trauma care | |
Khowaja et al. | Internet of Everything enabled solution for COVID-19, its new variants and future pandemics: Framework, Challenges, and Research Directions | |
Gamboa et al. | Attention classification based on biosignals during standard cognitive tasks for occupational domains | |
Leitner et al. | Classification of patient recovery from COVID-19 symptoms using consumer wearables and machine learning | |
Lytaev | Psychological and neurophysiological screening investigation of the collective and personal stress resilience | |
Yadav et al. | A novel healthcare framework for ambient assisted living using the internet of medical things (IOMT) and deep neural network | |
Sani et al. | Review on hypertension diagnosis using expert system and wearable devices | |
Kamrud et al. | Generalized deep learning EEG models for cross-participant and cross-task detection of the vigilance decrement in sustained attention tasks | |
US20140164012A1 (en) | System and methods for simulating future medical episodes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221129 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240425 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240627 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240729 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240830 |